About BriaCell Therapeutics Corp.

Website
Website
Employees
Employees
11-50 employees View all
Industry
Industry
Biotechnology
Location
Location
2929 Arch St, 3rd Floor, Philadelphia, Pennsylvania 19104, US
Description
Information
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) is a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer. BriaCell achieved positive proof-of-concept in a Phase I/IIa clinical trial for Bria-IMT™ in patients with advanced breast cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT™ in combination with a PD-1 inhibitor, retifanlimab (provided by Incyte under a collaboration agreement). Additionally, BriaCell is developing Bria-OTS™, the first “off-the-shelf” personalized immunotherapy for advanced breast cancer. For additional information on BriaCell, please visit our website: http://briacell.com/

BriaCell Therapeutics Corp. Alternatives

Frequently Asked Questions about BriaCell Therapeutics Corp.

What is BriaCell Therapeutics Corp. email format?

The widely used BriaCell Therapeutics Corp. email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is BriaCell Therapeutics Corp. customer service number?

To contact BriaCell Therapeutics Corp. customer service number in your country click here to find.


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more